BioTrove, Inc. is a biotechnology company founded in 1997 that specializes in creating micro and nano-scale technology platforms for life science and drug discovery research. The company's OpenArray platform is tailored for relative gene expression analysis, driving advancements in genomic research across diverse fields such as agriculture, disease studies, and public health. Additionally, BioTrove's RapidFire platform facilitates the screening of challenging drug targets through mass spectrometry-based assay development. Notably, the RapidFire mass spectrometry hardware system enables native detection technology for drug screening and in vitro ADME applications.
With its focus on empowering genomic research and drug discovery, BioTrove aims to make impactful advancements in the life sciences industry. The company's recent Series C investment at 22 April 2009 was secured from Excel Venture Management, signifying continued support and confidence from prominent investors in the company's innovative technology platforms. BioTrove operates within the biotechnology, healthcare, and life sciences industries, positioning itself at the forefront of technological advancements and research breakthroughs in these fields.
Overall, BioTrove's targeted use of micro and nano-scale technology platforms, combined with its strategic focus on genomic research and drug discovery, positions the company as a promising player in the life sciences industry, with significant potential for further growth and impact in the coming years.
